CAMBRIDGE, UK (2019-12-17) – ProteinLogic, the biomarker discovery and exploitation company, has been selected by UKRI to present at the prestigious BioSeed event.
BioSeed is an early-stage life-sciences investment event, which provides a platform for only 60 innovative early-stage Life Sciences companies to present to over 100 specialist investors. The pitching session is followed by extensive one-to-one partnering as well as networking opportunities.
Dr Nicolas Huber, CEO of ProteinLogic, commented: “The innovative work we have done at ProteinLogic, and its potential social impact, continuous to be recognised, both in the UK and abroad. We are particularly pleased of the continued support by Innovate UK – UKRI in promoting us as a company worthy of investment. We are looking forward to presenting our work to the wider investment community.”
BioSeed2020 is taking place on the 20th of January in London.